Time to limbo
For better or worse Teladoc has become the de facto gauge for digital/virtual health. At the height of Covid shares soared to $300+ but as Covid has subsided shares have fallen below $150. Along the way the company used their soaring price to value Livongo at a whopping $19 Billion which now looks a huge misstep. Something we said many times but hey being right is what we do around here.
The real question we have is just how far shares will fall before they hit bottom. The next earnings report for Teladoc is July 27th which should give . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.